Melbourne, Vic, September 21, 2021 – CANNect Group (“CANNect Group” or the “Company”), a platform provider which provides medical professionals clinical tools they need to enable a compliant, streamlined and informed approach to prescribing new medicines is pleased to announce that public consultations are now open on proposed amendments to the Poisons Standard. The public is now able to give their input on allowing veterinary use of cannabinoid medications (THC/CBD) on animals. At the present time, Schedule 8 of the Poisons Standard only allows for therapeutic use on humans. This would be a significant win for the field of cannabinoid medicines and an overall improvement to the medical system for animals under veterinary care.
All submissions received by 7 October, 2021 will be considered by the delegate before they make an interim decision.
